BRENT NORTH: Open Payments
NPI 1104155761 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 8 companies in 2025. Trend: 2023 $373 · 2024 $765 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Abbott Laboratories | 1 | $28 |
| Dexcom, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: ROTATEQ, MOUNJARO, GVOKE HYPOPEN, Kerendia, FREESTYLE LIBRE 3, Ozempic, Dexcom G6 Transmitter, FARXIGA.
Industry payments across CA — which companies pay providers there.
